Jefferies Downgrades Regeneron Pharma (REGN) to Hold, Sees Limited Eylea Upside
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steadies as US fuel demand concerns face Middle East supply risks
- Dollar sags after US GDP and inflation surprise, except against yen
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Brean Capital Downgrades Regeneron Pharma (REGN) to Hold
January 17, 2013 8:23 AM ESTBrean Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Buy to Hold saying it would be increasingly difficult for the company to substantially beat consensus as it had quite easily throughout 2012, regardless of a new indication and ex-U.S. approvals.
For an analyst... More
Baird Releases Bullish Note on Regeneron (REGN), Eylea Taking Share
January 15, 2013 2:23 PM ESTToday analysts a Baird put out a very bullish note on Regeneron Pharma (NASDAQ: REGN). In the note, analysts reiterated an Outperform rating and raised thier price target to $205.00 (from $176.00). Analyst also noted strong uptake of Eylea, which continues to take share from Lucentis... More